Paul Tudor Jones’s Novo Nordisk NVO Stock Holding History

Paul Tudor Jones’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$27.2M	Sell	568,000 -463,000	-45%	-$19.9M	0.04%	363
2026 Q1	$37.9M	Sell	1,031,000 -73,300	-7%	-$3.47M	0.07%	206
2025 Q4	$56.2M	Buy	1,104,300 +209,200	+23%	+$10.7M	0.1%	141
2025 Q3	$49.7M	Buy	895,100 +479,600	+115%	+$28.1M	0.09%	177
2025 Q2	$28.7M	Buy	415,500 +59,300	+17%	+$4.03M	0.06%	241
2025 Q1	$24.7M	Buy	356,200 +298,900	+522%	+$24.7M	0.08%	155
2024 Q4	$4.93M	Buy	57,300 +39,800	+227%	+$4.3M	0.02%	703
2024 Q3	$2.08M	Buy	17,500 +10,400	+146%	+$1.39M	0.01%	1177
2024 Q2	$1.01M	Buy	+7,100	New	+$941K	0.01%	1452
2024 Q1	–	Sell	-5,700	Closed	-$590K	–	2624
2023 Q4	$590K	Sell	5,700 -900	-14%	-$89K	﹤0.01%	1711
2023 Q3	$600K	Buy	+6,600	New	+$581K	0.01%	1586

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Paul Tudor Jones's NVO Position: Q2 2026 in Review

Paul Tudor Jones reduced its Novo Nordisk (NVO) stake by 59% in Q2 2026, selling an estimated $11.1M and leaving 182,382 shares worth $8.74M. The position accounts for 0.01% of the portfolio, ranked #901.

Paul Tudor Jones first reported a position in NVO in Q4 2021 and has held it in 13 quarters since. The position peaked at $22M in Q4 2023. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Paul Tudor Jones held 182,382 shares of Novo Nordisk worth $8.74M as of Q2 2026.
Paul Tudor Jones sold 258,235 Novo Nordisk shares in Q2 2026, an estimated $11.1M.
Novo Nordisk made up 0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #901 holding.
Paul Tudor Jones first reported a position in Novo Nordisk in Q4 2021 and has held it in 13 quarters since.
Paul Tudor Jones's Novo Nordisk position peaked at $22M in Q4 2023.
1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.